We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.39B
1-Year Est. Return 1.06%
This Fund
S&P 500
This Quarter Est. Return
+16.38%
1 Year Est. Return
-1.06%
3 Year Est. Return
+72.63%
5 Year Est. Return
+112.03%
10 Year Est. Return
+415.67%
AUM
$1.46B
AUM Growth
+$222M
Cap. Flow
+$49.8M
Cap. Flow %
3.4%
Top 10 Hldgs %
67.23%
Holding
266
New
5
Increased
172
Reduced
10
Closed
8

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$167M
2
AMZN icon
Amazon
AMZN
+$5.51M
3
ABT icon
Abbott
ABT
+$4.26M
4
AGN
Allergan plc
AGN
+$2.31M
5
XYZ
Block Inc
XYZ
+$2.26M

Top Sells

Rank Stock Value
1
SH icon
ProShares Short S&P500
SH
+$1.73M
2
ADT
ADT Corp
ADT
+$915K
3
SDS icon
ProShares UltraShort S&P500
SDS
+$791K
4
KMI icon
Kinder Morgan
KMI
+$550K
5
MO icon
Altria Group
MO
+$425K

Sector Composition

Rank Sector Weight
1 Healthcare 58.41%
2 Energy 12.88%
3 Utilities 5.3%
4 Consumer Staples 4.25%
5 Communication Services 3.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KO icon
76
Coca-Cola
KO
$381B
$2.39M 0.16%
52,652
+390
+0.7% +$17.6K
MS icon
77
Morgan Stanley
MS
$330B
$2.31M 0.16%
89,023
-4,542
-5% -$119K
AGN
78
DELISTED
Allergan plc
AGN
$2.31M 0.16%
+10,000
New +$2.31M
NNN icon
79
NNN REIT
NNN
$9.16B
$2.31M 0.16%
44,672
+401
+0.9% +$18.6K
PFE icon
80
Pfizer
PFE
$142B
$2.3M 0.16%
68,931
+462
+0.7% +$14.7K
RYN icon
81
Rayonier
RYN
$6.43B
$2.28M 0.16%
95,587
+918
+1% +$21.1K
CINF icon
82
Cincinnati Financial
CINF
$26.8B
$2.25M 0.15%
30,008
+216
+0.7% +$14.7K
COST icon
83
Costco
COST
$423B
$2.12M 0.14%
13,476
– –
GSK icon
84
GSK
GSK
$104B
$2.11M 0.14%
38,986
+14,888
+62% +$784K
SNN icon
85
Smith & Nephew
SNN
$13.6B
$2.06M 0.14%
60,025
+21,925
+58% +$742K
GS icon
86
Goldman Sachs
GS
$302B
$2.06M 0.14%
13,835
+56
+0.4% +$8.74K
AAPL icon
87
Apple
AAPL
$4.9T
$2.04M 0.14%
85,272
+12
+0% +$298
GPC icon
88
Genuine Parts
GPC
$17.2B
$2.02M 0.14%
19,942
+129
+0.7% +$12.5K
CMG icon
89
Chipotle Mexican Grill
CMG
$48.8B
$1.93M 0.13%
+240,000
New +$2.09M
PG icon
90
Procter & Gamble
PG
$335B
$1.86M 0.13%
21,933
+178
+0.8% +$14.6K
BNS icon
91
Scotiabank
BNS
$107B
$1.81M 0.12%
36,990
-526
-1% -$25.9K
XYZ
92
Block Inc
XYZ
$49.2B
$1.81M 0.12%
+200,000
New +$2.26M
UL icon
93
Unilever
UL
$141B
$1.78M 0.12%
33,054
+258
+0.8% +$13.2K
TRP icon
94
TC Energy
TRP
$70.9B
$1.76M 0.12%
38,936
+189
+0.5% +$7.8K
RTX icon
95
RTX Corp
RTX
$289B
$1.75M 0.12%
27,092
+1
+0% +$64
NI icon
96
NiSource
NI
$21.6B
$1.74M 0.12%
65,775
+413
+0.6% +$9.91K
DIS icon
97
Walt Disney
DIS
$167B
$1.74M 0.12%
17,763
– –
ACN icon
98
Accenture
ACN
$99.9B
$1.73M 0.12%
15,271
– –
WBK
99
DELISTED
Westpac Banking Corporation
WBK
$1.73M 0.12%
78,224
– –
BAC icon
100
Bank of America
BAC
$433B
$1.71M 0.12%
128,832
+429
+0.3% +$6.03K
2 3
4
5 6

Similar funds

BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return

Bollard Group's Q2 2016 Portfolio in Review

As of Q2 2016, Bollard Group held 266 positions worth $1.46B, up 18% from $1.24B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Bollard Group deployed $49.8M of net new capital in Q2 2016, opening 5 new positions and adding to 172 existing holdings. Its largest new stake was Allergan plc: 10,000 shares worth $2.31M.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 44% a quarter earlier, followed by Energy and Utilities.

On the sell side, the largest reduction was ProShares Short S&P500, an estimated $1.73M trimmed.

  • Bollard Group's largest Q2 2016 buy was Allergan plc: 10,000 shares worth $2.31M.
  • Bollard Group added most to Boston Scientific in Q2 2016, an estimated $167M increase.
  • Bollard Group's biggest Q2 2016 reduction was ProShares Short S&P500, cutting an estimated $1.73M.
  • Bollard Group fully exited ADT Corp in Q2 2016, selling an estimated $915K.
  • Bollard Group's ten largest holdings make up 67% of its $1.46B portfolio in Q2 2016.
  • Bollard Group opened 5 new positions and closed 8 in Q2 2016.
  • Bollard Group's portfolio value rose 18% quarter-over-quarter to $1.46B.

Based on Bollard Group's 13F filing for Q2 2016, filed 20 Jul 2016.